Stay updated on TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial
Sign up to get notified when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.

Latest updates to the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe study location listing was updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' by adding the new location and removing the older one. A funding notice banner was removed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedExternal resource links at the bottom of the Study Details page were removed, including DailyMed, PubMed searches, vivli, and several government sites. This reduces quick access to supporting documents but does not change the core study information such as eligibility, design, outcomes, or locations.SummaryDifference0.2%

- Check46 days agoChange DetectedMajor update to version 3.2.0 accompanied by a government-status notice; removes the old v3.1.0 reference and adds operating-status details.SummaryDifference1%

- Check54 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0; new contact numbers added for support/hours.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page addition “Last Update Posted (Estimated)” replaces the deletion “Last Update Posted”, indicating the site now displays an estimated timestamp for the last update instead of an exact one.SummaryDifference0.0%

- Check68 days agoChange DetectedNew recruitment sites added worldwide, location count increased to 252, and revision updated to v3.0.2 with recent dates; older Jiamusi entries and certain recruiting details were removed.SummaryDifference6%

Stay in the know with updates to TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TROPION-Lung07: Dato-DXd vs Pembrolizumab in 1L NSCLC Clinical Trial page.